Before starting Spravato treatment, all patients must enroll in the Spravato REMS program (Risk Evaluation and Mitigation Strategy), this is a requirement from the FDA to receive Spravato.

You will be emailed the REMS enrollment form after booking your first Spravato appointment. Please make sure you sign this as quickly as possible to prevent any delays to your first treatment.